Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose
The omicron variant of SARS-CoV-2 infected very large numbers of SARS-CoV-2 vaccinated and convalescent individuals 1–3.
Pfizer plans to submit data on a 4th Covid shot to FDA
Pfizer is close to submitting data to the Food and Drug Administration on a fourth dose of its Covid-19 vaccine, according to CEO Albert Bourla.
Omicron BA.2 sub-variant now nearly a quarter of new COVID cases in U.S., CDC estimates
The BA.2 sub-lineage of the Omicron variant now makes up nearly a quarter of new COVID-19 infections nationwide, the Centers for Disease Control and Prevention estimated Tuesday, up from around 1 in 10 new cases just a week prior.
Pfizer and BioNTech launch clinical trial of Covid vaccine targeting omicron
Pfizer and BioNTech on Tuesday launched a clinical trial to evaluate the safety and effectiveness of a vaccine that targets the Covid omicron variant, as concerns grow that the current shots aren’t holding up against infections and mild illness caused by the strain discovered just over two months ago
ViiV Healthcare Reports Positive Phase III Study Results
ViiV Healthcare Reports Positive Phase III Study Results Of Investigational, Long-Acting, Injectable HIV-treatment Regimen Administered Every Two Months